来自MSN10 小时
Windtree Therapeutics Highlights Istaroxime’s Promise for Cardiogenic Shock
Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...